Chemoinformaics analysis of S-allylmercapto-L-cysteine
Molecular Weight | 193.293 | nRot | 6 |
Heavy Atom Molecular Weight | 182.205 | nRig | 2 |
Exact Molecular Weight | 193.023 | nRing | 0 |
Solubility: LogS | -2.725 | nHRing | 0 |
Solubility: LogP | -2.035 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 25.8587 |
nHD | 1 | BPOL | 14.0913 |
QED | 0.374 |
Synth | 3.651 |
Natural Product Likeliness | 1.543 |
NR-PPAR-gamma | 0.267 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.01 |
CACO-2 | -5.355 |
MDCK | 0.0000102 |
BBB | 0.584 |
PPB | 0.449535 |
VDSS | 0.441 |
FU | 0.355517 |
CYP1A2-inh | 0.02 |
CYP1A2-sub | 0.088 |
CYP2c19-inh | 0.045 |
CYP2c19-sub | 0.062 |
CYP2c9-inh | 0.089 |
CYP2c9-sub | 0.524 |
CYP2d6-inh | 0.029 |
CYP2d6-sub | 0.375 |
CYP3a4-inh | 0.019 |
CYP3a4-sub | 0.072 |
CL | 12.136 |
T12 | 0.774 |
hERG | 0.018 |
Ames | 0.256 |
ROA | 0.722 |
SkinSen | 0.747 |
Carcinogencity | 0.275 |
EI | 0.2 |
Respiratory | 0.913 |
NR-Aromatase | 0.027 |
Antiviral | No |
Prediction | 0.930126 |